Skip to main content

Legacy of innovation, vision for the future

Laboratory tech using QuidelOrtho product

550

Assays offered

140+

Countries and territories around the world

What we stand for

Caring for people, families and the communities where we live is what guides our work at QuidelOrtho. Explore the links below to learn more about what we stand for and how we meet this opportunity every day.

Press Release 10/29/26

Transforming Data Into Actionable Insights in the Lab
Learn more

Press Release 10/15/26

QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Learn more

Press Release 10/07/26

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
Learn more

Press Release 09/24/26

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment
Learn more

Press Release 08/06/26

QuidelOrtho Reports Second Quarter 2026 Financial Results
Learn more

Press Release 07/23/26

Beyond Fentanyl: How the Drug Crisis Is Changing
Learn more

Press Release 07/15/26

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Learn more

Press Release 06/23/26

QuidelOrtho Appoints Micah Young as Chief Financial Officer
Learn more

Press Release 06/02/26

QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies
Learn more

Press Release 05/21/26

When Blood Compatibility Becomes a Pregnancy Risk
Learn more

Press Release 05/20/26

QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
Learn more

Press Release 05/05/26

QuidelOrtho Reports First Quarter 2026 Financial Results
Learn more